Lynntech Inc.

Lynntech Inc. is a small business technology development company based in College Station, Texas, specializing in transitioning innovative science and engineering solutions into real-world applications for federal government agencies. The company provides comprehensive research, development, testing, and evaluation services across multiple technology domains, with a particular focus on advanced energy technologies, sensors, robotics, artificial intelligence, medical devices, and environmental solutions. Through its robust engagement with federal agencies, Lynntech consistently demonstrates capabilities in developing cutting-edge technologies that address complex challenges in defense, health, energy, and scientific research.

Lynntech Inc. has an extensive track record of providing goods and services through federal contract awards, primarily through Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. The company has received numerous prime contract awards from agencies including the Department of Defense (Air Force Research Laboratory, Naval Air Warfare Center, Army Research Development and Engineering Command), Department of Homeland Security, NASA, and the National Institutes of Health. These contracts span a wide range of technological developments, such as advanced battery technologies, energy harvesting systems, medical diagnostics, sensor technologies, thermal protection systems, and innovative materials research. Most of these contracts are designated as total small business set-asides, reflecting Lynntech's commitment to fostering innovation within the small business community. The contract work typically involves Phase I and Phase II research efforts aimed at developing and demonstrating the feasibility of novel technological solutions.

In terms of federal grant awards, Lynntech Inc. has secured project grants from agencies like the National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases, and the National Oceanic and Atmospheric Administration. These grants have supported diverse research initiatives, including developing software for optimizing self-amplifying RNA replication, creating cutaneous gels for diabetic foot ulcer treatment, developing diagnostic assays for viral RNA detection, and creating rapid identification methods for seafood species. The grant work demonstrates Lynntech's versatility in addressing critical challenges across medical, biological, and environmental domains, often collaborating with academic institutions to advance scientific research and develop innovative solutions.

Lynntech Inc. holds a Basic Ordering Agreement (BOA) with the Naval Air Warfare Center, awarded on December 19, 2024, with an ultimate completion date of December 18, 2029. This BOA is designed to facilitate the procurement of SBIR Phase III research, development, testing, and evaluation services. As a single-award IDV without a specified ceiling value, the agreement provides a flexible mechanism for the Navy to acquire specialized technical services and products from Lynntech as needed. The BOA reflects the company's established reputation for delivering innovative solutions and its ongoing relationship with defense research entities, enabling efficient procurement of advanced technological services across various research and development domains.

Lynntech scientists and engineers develop world-class technology solutions for aerospace, defense and human health. Our interdisciplinary approach and dedication to performance have driven innovation for more than 25 years.